Learning Objectives ~ upon conclusion of this program, participants should be able to:
- Review the prevalence and impact of opioid misuse in Arizona
- Recognize the new AZ state requirements for opioid prescribing
- Discuss the new enterprise tools and protocols for opioid prescribing
Date/Time: Friday, September 7, 2018 | 12:15 – 1:15 PM
Holly L. Geyer, M.D.
Consultant, Department of Internal Medicine, Division of Hospital Internal Medicine
Assistant Professor of Medicine, College of Medicine
Mayo Clinic, Phoenix, Arizona
Eric A. Nelson, R.Ph.
Director, Pharmacy
Operations Administrator, Center for Individualized Medicine, Department of Clinical Genomics
Assistant Professor of Pharmacy, College of Medicine
Mayo Clinic, Phoenix, Arizona
Michael Grafton
Diversion Program Manager, Drug Enforcement Administration, Phoenix Field Division
Drug Enforcement Agency, Phoenix, Arizona
Innovation Presentation: Jan Stepanek, M.D., M.P.H. – Preventive Occupational and Aerospace Medicine
LOCATIONS: Phoenix Campus, Waugh Auditorium, Side A | Scottsdale Campus, Mayo Clinic Building - Taylor Auditorium | Other video conf locations: Mayo Clinic Primary Care-Phoenix Campus, Mayo Clinic Women's Health Internal Medicine-Thunderbird, Mayo Clinic Family Medicine-Arrowhead, Canyon Ranch Medicine Center, San Tan Medical Center
To receive CME credit and record attendance, text the unique presentation code to 507-200-3010
Trainees must ALSO swipe to record their attendance. Attendees must be present to receive code.
ABOUT Internal Medicine Grand Rounds are held weekly on Fridays for all physicians and allied health staff.
ADDITIONAL INFORMATION Lunch will be served on the Scottsdale and Phoenix campuses only.
ARCHIVED PRESENTATIONS Located in Internal Medicine, Department of -ARZ video library at http://intranet.mayo.edu/charlie/internal-medicine-arz/home/archived-grand-rounds/.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.

Facebook
X
LinkedIn
Forward